Trogenix
Developer of a proprietary genetic medicine platform designed to develop precision cancer treatments that selectively target diseased cell states and behaviors. The company offers payloads that reveal...
Valuation
$0
Share Price
N/A
Total Raised
$110.5M
Last Round
N/A